French startup that develops computer vision software and robotics technologies for orthopaedic surgeons, Ganymed Robotics has raised €21 million in funding. The oversubscribed Series B round was led by Cathay Health, with participation from Credit Mutuel Innovation, Kurma Partners, BNP Paribas Développement and internationally renowned surgeons.
The funding will be used to support Ganymed’s expansion in France and in the U.S., finalise the industrial development of its surgical robotic assistant for knee arthroplasty (TKA), accelerate regulatory and marketing developments across geographies and diversify the product pipeline.
Founded in 2018, Ganymed Robotics aims to empower orthopaedic surgeons in the operating room. Its first application is a co-manipulated surgical robotic assistant for TKA. The company claims the compact and intuitive robot simplifies and increases the accuracy of orthopedics.
Sophie Cahen, co-founder and CEO of Ganymed Robotics said: “With our unique robot-with-eyes platform, we are committed to providing all surgeons and care centres, large and small, with an easy-to-use and cost-effective solution that will radically improve patient outcome, surgeon experience and overall efficiency of joint replacement interventions.”